Navigation Links
Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008

Findings Include 80% SVR12 Rate with Nitazoxanide-Based Combination Therapy

and New Insights into Mechanism of Action of Nitazoxanide

MILAN, Italy, April 23 /PRNewswire/ -- Romark Laboratories, a privately held biopharmaceutical company, today announced that data from studies of nitazoxanide in chronic hepatitis C virus (HCV) infection are being communicated in four presentations made at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), held in Milan, Italy this week.

"These new studies confirm earlier data suggesting synergistic activity between nitazoxanide and peginterferon in genotype 4 patients and provide a first look at sustained virologic response in a limited number of genotype 1 patients," said Jean-Francois Rossignol, M.D., Director of the Romark Institute for Medical Research and discoverer of nitazoxanide. "These data also provide interesting insights into the mechanism of action of nitazoxanide and confirm previous findings related to its safety."

The four presentations include:

-- An oral presentation, titled, "Randomized Controlled Trial of

Nitazoxanide-Peginterferon-Ribavirin, Nitazoxanide-Peginterferon and

Peginterferon-Ribavirin in the Treatment of Patients with Chronic

Hepatitis C Genotype 4," reported final 24-week post-treatment

sustained virologic response (SVR) rates for the company's STEALTH C-1


In the trial, 96 treatment-naive patients with chronic hepatitis C

genotype 4 were randomized into three groups to receive either 48 weeks

of standard of care (SOC) treatment (n=40), 12 weeks of nitazoxanide

followed by 36 weeks of nitazoxanide plus peginterferon (a dual regimen,

n=28), or 12 weeks of nitazoxanide followed by 36 weeks of nitazoxanide

plus SOC with peginterferon plus ribavirin (a triple regimen, n=28). An

additional 24 interferon-experi

SOURCE Romark Laboratories
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
2. Romark Laboratories Raises $18 Million in Institutional Financing
3. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
(Date:10/8/2015)... , Oct. 8, 2015  The National Heart, ... $40 million to the Broad Institute of MIT ... of 20,000 individuals, as well as data to ... profiling. Trans-Omics for Precision Medicine ... toward a larger initiative, which will use whole ...
(Date:10/8/2015)...  Nektar Therapeutics (Nasdaq: NKTR ) will present ... during an Investor and Analyst R&D Day being hosted ... New York City . ... 1/2 clinical program and biomarker strategy will be presented.  ... stimulate the production of CD8-positive T-cells.  The Company will ...
(Date:10/8/2015)... -- CareDx, Inc. (NASDAQ: CDNA ), a molecular diagnostics company, ... the Centers for Medicare & Medicaid Services (CMS) to drastically ... gene expression levels to help clinicians determine a heart transplant ... of this story on CNBC . [ Link ... on CNBC . [ Link ] --> ...
Breaking Medicine Technology:
... , BERKELEY HEIGHTS, N.J. , June 15 Access ... president and chief executive officer (CEO). Since mid-2009, Access was under the ... served in addition to his responsibilities as chief financial officer (CFO). ... "I am humbled and ...
... June 15 Eleme Medical Inc., a ... all areas of body shaping, announced today that CEO ... recipient of a Leadership Award from non-profit group Women ... scientists and engineers to develop an entrepreneurial mindset and ...
Cached Medicine Technology:
(Date:10/9/2015)... ... October 09, 2015 , ... Matrix IT Medical ... specifications for TRACTUS, the world’s first sterile field scanner. , The ... to the FDA’s recent Unique Device Identifier (UDI) Final Rule, which will require ...
(Date:10/9/2015)... PA (PRWEB) , ... October 09, 2015 , ... "As ... of two inventors from Philadelphia, Pa. "They have to wear large diapers or pads. ... solutions." , They developed the TROUSAFE to absorb urine leaking from the tip of ...
(Date:10/9/2015)... ... October 09, 2015 , ... Ryan Fox, the ... recreational dispensaries in Colorado, says the latest figures on the state’s sales of ... into a legitimate industry. , Last month, according to the website ...
(Date:10/9/2015)... Carolina (PRWEB) , ... October 09, 2015 , ... ... care and medical staffing franchise, was recognized by Cabarrus County Active Living and ... the local home care company’s dedication to consistently going above and ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... ... in Franklin County, North Carolina and nearby communities, launched a new website to ... allows victims of domestic violence to find help immediately, whether through an emergency ...
Breaking Medicine News(10 mins):
... Coastal Health Research Institute study has found that a ... of developing bone necrosis, a condition that can lead ... the largest study of bone necrosis and bisphosphonates, a ... to help prevent bone fractures due to osteoporosis. It ...
... protect against spread of disease , TUESDAY, Jan. 15 ... with HIV might also prevent vaginal transmission of the ... of Texas Southwestern Medical Center at Dallas. , The ... about 6,800 new transmissions daily, occur through unprotected vaginal ...
... for imported food increases, the urgency for quality controls does ... (HealthDay News) -- One Sunday after church, Rich Miller headed ... he dipped into the house salsa that came with the ... life forever. What Miller didn,t know was that imported Mexican ...
... pulmonary fibrosis (IPF), an untreatable progressive lung disease that ... diagnosis, have a worse prognosis than non-smokers, according to ... that current smokers with IPF might live longer than ... likely reflected a healthy smoker effect. , The study ...
... with an education platform to start a dialogue,with ... Papillomavirus (HPV),cervical cancer preventative vaccines., VAN NUYS, ... (NCCC) announces the formation of four new,chapters nationwide ... communities about the cervical cancer HPV preventative vaccines. ...
... LOS ANGELES, Jan. 15 It,s time to think about ... star on the high school golf,circuit in southern California., ... competing in tournaments, I am,constantly doing a variety of things ... Here are some ideas to get ...
Cached Medicine News:
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: